Partnered status and receipt of guideline-concordant adjuvant chemotherapy among patients with colon cancer.

ABSTRACT:

Background

Partnered status is an independent predictor of clinical outcomes, including overall survival, among patients with cancer. However, the mechanisms by which partnered status impacts survival are not fully understood and to the authors' knowledge the associations between partnered status and the specific attributes of chemotherapy have not been studied to date.

Methods

The current study was an observational study of patients with resected American Joint Committee on Cancer (AJCC) stage III colon cancer diagnosed from 2008 through 2015 and recruited from an academic cancer center and 2 large community oncology practices. Outcome measures were specific attributes of adjuvant chemotherapy. Partnered status (partnered vs unpartnered) was the primary independent variable

SUBMITTER: Veenstra CM 

PROVIDER: S-EPMC6856404 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature